Major depressive disorder (MDD) affects approximately 280 million people globally and is one of the leading causes of ...

Treatment with esketamine combined with an SNRI is linked to fewer adverse outcomes than treatment with an SSRI alone.

Still, the experts said esketamine has some important negative ... by ketamine Whether it's Abilify or Zoloft, almost all antidepressants work by plugging up the places where our brain takes ...

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one roof would be ideal.

Both drugs were given on top of standard antidepressants to patients wo ... "This provides further evidence for the use of esketamine nasal spray in this difficult-to-treat population and offers ...

Esketamine is a more potent version of ketamine ... heads a study on the antidepressant effects of psilocybin, a hallucinogenic substance obtained from certain types of (“magic”) mushrooms.

This mechanism is distinct from traditional antidepressants, which primarily target serotonin and norepinephrine. Esketamine's rapid onset of action, often providing relief within hours ...

Ketamine, not esketamine, is not FDA-approved for the treatment of ... In addition, ketamine’s molecular structure and properties do not match those of traditional antidepressants, Garlow said. This ...